Jon Kuwahara, See Remarks at Novus Therapeutics, Inc. (NVUS), sold 5,276 shares at $1.91 ($10K) on 2019-05-21, disclosed to the SEC on 2019-05-22.
Open-market sale of $10k NVUS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.96 | 4,218 | $8K | 80.4% |
| 2 | $1.91 | 1,058 | $2K | 19.6% |
| Total | $1.95 avg | 5,276 | $10K | 100% |